Atai Life Sciences EBITDA Margin 2020-2024 | ATAI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Atai Life Sciences (ATAI) over the last 10 years. The current EBITDA margin for Atai Life Sciences as of March 31, 2024 is .
| Atai Life Sciences EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $0.00B | $-0.13B | inf% |
| 2023-09-30 | $0.00B | $-0.13B | inf% |
| 2023-06-30 | $0.00B | $-0.14B | inf% |
| 2023-03-31 | $0.00B | $-0.14B | inf% |
| 2022-09-30 | $0.00B | $-0.15B | inf% |
| 2022-06-30 | $0.00B | $-0.15B | inf% |
| 2021-12-31 | $0.02B | $-0.14B | -675.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.223B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.800B | 0.00 |
| Quest Diagnostics (DGX) | United States | $15.206B | 15.72 |
| DaVita (DVA) | United States | $12.153B | 15.10 |
| Encompass Health (EHC) | United States | $8.638B | 22.11 |
| Chemed (CHE) | United States | $8.214B | 25.46 |
| Elanco Animal Health (ELAN) | United States | $7.131B | 18.50 |
| Option Care Health (OPCH) | United States | $4.815B | 18.22 |
| RadNet (RDNT) | United States | $4.353B | 90.65 |
| Amedisys (AMED) | United States | $3.000B | 21.25 |
| Astrana Health (ASTH) | United States | $2.272B | 30.73 |
| Addus HomeCare (ADUS) | United States | $1.901B | 27.19 |
| LifeStance Health (LFST) | United States | $1.877B | 0.00 |
| U.S Physical Therapy (USPH) | United States | $1.393B | 37.27 |
| Pennant (PNTG) | United States | $0.697B | 36.81 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.531B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.020B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.014B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |